Total Payments
$682.13
2024 Payments
$163.32
Companies
8
Transactions
19
Medicare Patients
1,431
Medicare Billing
$124,791
Payment Breakdown by Category
Food & Beverage$568.25 (83.3%)
Education$113.88 (16.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $568.25 | 17 | 83.3% |
| Education | $113.88 | 2 | 16.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $246.43 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $129.45 | 3 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $85.79 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $64.89 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $58.08 | 2 | $0 (2024) |
| PFIZER INC. | $41.56 | 2 | $0 (2023) |
| Amgen Inc. | $40.18 | 2 | $0 (2023) |
| Esperion Therapeutics, Inc. | $15.75 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.32 | 6 | Boston Scientific Corporation ($48.62) |
| 2023 | $250.02 | 7 | AstraZeneca Pharmaceuticals LP ($99.99) |
| 2022 | $186.59 | 2 | Boston Scientific Corporation ($172.70) |
| 2021 | $82.20 | 4 | BOSTON SCIENTIFIC CORPORATION ($25.11) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.32 | General |
| Category: Cardiovascular | ||||||
| 08/22/2024 | Boston Scientific Corporation | VersaCross Access Solution (Device) | Food and Beverage | In-kind items and services | $48.62 | General |
| Category: VersaCross Access Solution_ICG | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $35.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/26/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Cardiovascular | ||||||
| 06/08/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $45.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/06/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/29/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Cardiology | ||||||
| 10/13/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $172.70 | General |
| Category: WATCHMAN_IC | ||||||
| 09/09/2021 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/09/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/19/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 284 | 379 | $117,805 | $27,535 |
| 2022 | 4 | 295 | 390 | $109,525 | $30,581 |
| 2021 | 7 | 367 | 463 | $123,150 | $35,360 |
| 2020 | 7 | 485 | 563 | $126,696 | $31,315 |
Total Patients
1,431
Total Services
1,795
Medicare Billing
$124,791
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 190 | 281 | $90,705 | $20,909 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 51 | $22,542 | $5,731 | 25.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $2,973 | $503.47 | 16.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 17 | 17 | $954.00 | $235.68 | 24.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 17 | 17 | $631.00 | $155.36 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 271 | $74,525 | $20,428 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 91 | $33,670 | $9,899 | 29.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 14 | 14 | $798.00 | $148.95 | 18.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 14 | 14 | $532.00 | $105.56 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 171 | 244 | $67,100 | $19,466 | 29.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 83 | 101 | $37,370 | $11,603 | 31.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 38 | 43 | $8,643 | $2,262 | 26.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 22 | 22 | $6,402 | $1,291 | 20.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 15 | 15 | $1,830 | $325.98 | 17.8% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 19 | 19 | $1,083 | $246.08 | 22.7% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 19 | 19 | $722.00 | $164.80 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 146 | 188 | $50,455 | $11,820 | 23.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 94 | 115 | $41,899 | $10,678 | 25.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 67 | 73 | $14,673 | $3,715 | 25.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 28 | 31 | $9,021 | $2,358 | 26.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 40 | 44 | $5,368 | $1,310 | 24.4% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 55 | 56 | $3,168 | $858.96 | 27.1% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 55 | 56 | $2,112 | $574.83 | 27.2% |
About Skye Nehs, PAC
Skye Nehs, PAC is a Naturopath healthcare provider based in Gresham, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2009. The National Provider Identifier (NPI) number assigned to this provider is 1740515097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Skye Nehs, PAC has received a total of $682.13 in payments from pharmaceutical and medical device companies, with $163.32 received in 2024. These payments were reported across 19 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($568.25).
As a Medicare-enrolled provider, Nehs has provided services to 1,431 Medicare beneficiaries, totaling 1,795 services with total Medicare billing of $124,791. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Naturopath
- Other Specialties Medical
- Location Gresham, OR
- Active Since 10/05/2009
- Last Updated 02/06/2020
- Taxonomy Code 175F00000X
- Entity Type Individual
- NPI Number 1740515097
Products in Payments
- WATCHMAN Access System (Device) $172.70
- BRILINTA (Drug) $99.99
- LifeVest (Device) $85.79
- VersaCross Access Solution (Device) $48.62
- VYNDAQEL (Drug) $41.56
- Repatha (Biological) $40.18
- CAMZYOS (Drug) $39.57
- LEQVIO (Drug) $35.16
- ELIQUIS (Drug) $25.32
- WATCHMAN (Device) $25.11
- ENTRESTO (Drug) $22.92
- NEXLETOL (Drug) $15.75
- LOKELMA (Drug) $15.57
- FARXIGA (Drug) $13.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.